Mark Fortner

Mark Fortner

@markfortner.bsky.social

CEO @ https://aspen.bio, Helping R&D Leaders Transform Their Drug Discovery Operations with AI & Automation |Creator of The Ring of Fire Portfolio & Project Management Framework

674 followers766 following1.6K posts

Pinned

Mark Fortner
@markfortner.bsky.social

Evaluating pharma assets isn't a one-and-done decision—it requires continuous, data-driven assessment. 🧬 The Ring of Fire delivers real-time confidence scores across Literature, Biology, Chemistry, Clinic, & Commercial metrics. 🎯 #Biotech #AI #Pharma #PM #PPM

Mark Fortner
@markfortner.bsky.social

When both of my dogs were diagnosed with sarcomas, I was surprised to discover the appalling state of veterinary oncology. Having worked for pharma and biotech companies with large oncology TAs and comparative medicine groups, it was surprising to discover that the Medicines that were at one point

Ron Leuty@rleutybiotech.bsky.social

It started with Lily the French bulldog's brain tumor. Now this Bay Area startup is ready to take into the clinic its first cancer drug for dogs www.bizjournals.com/sanfrancisco...

bizjournals.comLily the French bulldog’s brain tumor spurred these biotech veterans to launch a startup - San Francisco Business TimesAfter Lily the French bulldog was diagnosed with a brain tumor, these biotech veterans flew into action with a startup now prepping its first clinical trial.
Mark Fortner
@markfortner.bsky.social

On animals were not available to them. And standard molecular diagnostics used to recommend treatment options in humans, were not available in animals. Even companies that had an animal spinoff company (think Lilly and Elanco) didn't have a straight path between them.

Mark Fortner reposted

Ron Leuty
@rleutybiotech.bsky.social

It started with Lily the French bulldog's brain tumor. Now this Bay Area startup is ready to take into the clinic its first cancer drug for dogs www.bizjournals.com/sanfrancisco...

bizjournals.comLily the French bulldog’s brain tumor spurred these biotech veterans to launch a startup - San Francisco Business TimesAfter Lily the French bulldog was diagnosed with a brain tumor, these biotech veterans flew into action with a startup now prepping its first clinical trial.
Mark Fortner
@markfortner.bsky.social

🚗💼 Heading to a pitch meeting? Need a quick customer overview? Use Pharm2Market’s AI assistant for a hands-free conversation. Get their pipeline, news & leadership updates. Walk in prepared! #Biotech #News #Intelligence #Sales Got questions? Pharm2Market's got answers! bit.ly/3UfeaSG

Mark Fortner
@markfortner.bsky.social

Which San Diego biotechs are tackling cancer and expanding? Pharm2Market’s Biotech Hub brings you regional news, events, and venture capital trends. Perfect for founders, sales reps & job hunters! #Biotech #News #Intelligence 🌟 Got questions? Pharm2Market has the answers! bit.ly/3UfeaSG

Mark Fortner reposted

BF Francis Ouellette
@bffo.bsky.social

From @alexphd.bsky.social & colleagues in #OUP s @bioinfoadv.bsky.social journal | Bridge2AI recommendations for AI-ready genomic data | #Bioinformatics #AI #LLM #OpenScience #Genomics | 🧬🖥️🧪🔓 ⬇️ academic.oup.com/bioinformati...

academic.oup.comBridge2AI recommendations for AI-ready genomic dataAbstract. Rapid advancements in technology have led to an increased use of artificial intelligence (AI) technologies in medicine and bioinformatics researc

Mark Fortner reposted

George Takei
@georgetakei.bsky.social

My heart is heavy. Walter Koenig, our Ensign Pavel Chekov, passed away early today. Walter and I met on the bridge of the Enterprise in the 1960s, and we stayed friends for nearly six decades. When Brad and I married in 2008, Walter stood beside us as our best man.

Mark Fortner reposted

Ron Leuty
@rleutybiotech.bsky.social

Star Therapeutics enters new orbit with $200 million reset after a subsidiary's potential $2 billion buyout and a spinout's big IPO www.bizjournals.com/sanfrancisco...

bizjournals.comWith $200 million in funding, Adam Rosenthal's Star Therapeutics looks to enter a new drug-development orbit - San Francisco Business TimesAfter pulling off an IPO and a sale, Adam Rosenthal is ready to take his company into a "reset" with $200 million in fresh funding.
Mark Fortner
@markfortner.bsky.social

Evaluating pharma assets isn't a one-and-done decision—it requires continuous, data-driven assessment. 🧬 The Ring of Fire delivers real-time confidence scores across Literature, Biology, Chemistry, Clinic, & Commercial metrics. 🎯 #Biotech #AI #Pharma #PM #PPM

Mark Fortner
@markfortner.bsky.social

Curious about what fuels the top biotechs? 🚀 Dive into their origin stories, leadership, pipelines, and investors. Tune into Pharm2Market's Target Space podcast! Listen anywhere you get your podcasts or subscribe directly: bit.ly/4AN4HTh #Biotech #Podcasts

Mark Fortner
@markfortner.bsky.social

Got 8 minutes? Let us show you how the Pipeline Drug Discovery platform can transform your research operations, reduce risk & costs, and improve collaboration. Contact us at pipeline@aspen.bio youtu.be/K7SIBb7E34c #DrugDiscovery #AI #Assays #PM #Chem #ProteinProduction #TargetManagement

youtu.bePipeline OverviewGot 8 minutes? Let us show you how the Pipeline Drug Discovery platform can transform your research operations, reduce risk & costs, and improve communications & collaborations both inside and outside of the company. To learn more, contact us at pipeline@aspen.bio
Mark Fortner
@markfortner.bsky.social

9 out of 10 drugs fail to reach patients, actionable business intelligence can make all the difference. Pharm2Market's agentic AI delivers real-time industry news, regional hub analytics, company & investor profiles, networking events, and more. Checkout beta.pharm2market.app/ #BiotechFounders #VC

Mark Fortner
@markfortner.bsky.social

Biotech's biggest challenge? Choosing the next project! 🤔 We need a new way to evaluate beyond just finances. The Ring of Fire helps us gauge confidence in literature, biology, and market potential for smarter, data-driven choices. 🔍💡 #Biotech #Innovation #PortfolioManagement #PM

Mark Fortner
@markfortner.bsky.social

ESMO: Bristol Myers CMO touts ‘5 out of 5’ positive phase 3 trials for bispecific ADC iza-bren www.fiercepharma.com/pharma/brist... #biotech #pharma #biotechsky

fiercepharma.comESMO: Bristol Myers CMO touts ‘5 out of 5’ positive phase 3 trials for bispecific ADC iza-brenBuoyed by a clean sweep of five positive phase 3 readouts in China, Bristol Myers Squibb’s Chief Medical Officer, Cristian Massacesi, M.D., is voicing growing confidence in the company's first-in-c | ...
Mark Fortner
@markfortner.bsky.social

The Pipeline Drug Discovery Platform is your mission control for drug discovery programs. Helping you manage plan, manage and execute #DrugDiscovery programs, create protein target forms, create compound libraries and screen them. youtu.be/IYzzumfblKg #PM #PPM

Mark Fortner
@markfortner.bsky.social

The toughest choice for biotech? Deciding what to tackle next! 💡 We need a smarter way to evaluate projects, focusing on experiments that boost confidence or lead to a pivot. That's why we created the Ring of Fire! 🔥 #Biotech #DataDriven #PortfolioManagement #PPM

Mark Fortner
@markfortner.bsky.social

Which San Diego biotechs are tackling cancer and expanding? Pharm2Market’s Biotech Hub brings you regional news, events, and venture capital trends. Perfect for founders, sales reps & job hunters! #Biotech #News #Intelligence 🌟 Got questions? Pharm2Market has the answers! bit.ly/3UfeaSG

Mark Fortner
@markfortner.bsky.social

Where can I meet biotech founders, scientists and hiring teams near me? Find the right networking events for you on Pharm2Market. #Biotech #Networking #CareerOpportunities #Sales Got questions? Pharm2Market's got the answers. bit.ly/3UfeaSG

Mark Fortner
@markfortner.bsky.social

How do I catch up on the latest news? 🧬 With Pharm2Market, select your stories & our AI generates an audio broadcast. Perfect for your drive or workout! 🚗💪 #Biotech #Networking #CareerOpportunities #Sales Got questions? Pharm2Market's got the answers bit.ly/3UfeaSG

Mark Fortner
@markfortner.bsky.social

How do you stay updated on biotech trends during your commute? 🚗💨 Check out Pharm2Market for top podcasts like BioSpace, Fierce Biotech, and Target Space to catch up on the go! Got questions? Pharm2Market's got the answers. bit.ly/3UfeaSG #Biotech #Networking #CareerOpportunities #Sales

Mark Fortner
@markfortner.bsky.social

Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals www.fiercebiotech.com/biotech/trea... #biotechsky #biotech #pharma

fiercebiotech.comTreasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing dealsThe U.S. | Despite the sweeping scope of the ban covering various types of drug molecules, biopharma business development teams can breathe a measured sigh of relief.
Mark Fortner
@markfortner.bsky.social

🚗💼 Heading to a pitch meeting? Need a quick customer overview? Use Pharm2Market’s AI assistant for a hands-free conversation. Get their pipeline, news & leadership updates. Walk in prepared! #Biotech #News #Intelligence #Sales Got questions? Pharm2Market's got answers! bit.ly/3UfeaSG

Mark Fortner
@markfortner.bsky.social

‘It is what it is’: Merck exec unruffled by ‘unfortunate’ leak of ESMO cancer vaccine data www.fiercebiotech.com/biotech/it-w... #biotech #cancer #biotechsky #pharma

fiercebiotech.com‘It is what it is’: Merck exec unruffled by ‘unfortunate’ leak of ESMO cancer vaccine dataMerck & Co. and Moderna always knew they would be making headlines in Madrid this week—just not in the way it panned out. | Merck & Co. and Moderna always knew they would be making headlines in Madrid...

Mark Fortner reposted

STAT
@statnews.com

At last week’s #STATSummit, Dana Senaha told the story of her husband’s experience participating in the clinical trial for daraxonrasib. Watch: One family’s story of a life-extending medicine for pancreatic cancer https://bit.ly/4zVbNnP

statnews.comOne family’s story of a life-extending medicine for pancreatic cancerBobby Senaha was among the first patients to use daraxonrasib, a new life-extending drug for pancreatic cancer. His wife shares what those extra months meant to his family.